Public Sector Pension Investment Board Incyte Corp Transaction History

Public Sector Pension Investment Board

$23.4 Billion
Q4 2024

A detailed history of Public Sector Pension Investment Board transactions in Incyte Corp stock. As of the latest transaction made, Public Sector Pension Investment Board holds 19,684 shares of INCY stock, worth $1.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

19,684

Previous 6,622 197.25%

Holding current value

$1.4 Million

Previous $437,000 210.98%

% of portfolio

0.01%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$65.08 - $83.38 $850,074 - $1.09 Million	13,062 Added 197.25%	19,684 $1.36 Million
Q3 2024 Nov 14, 2024	BUY	$57.33 - $68.61 $17,199 - $20,583	300 Added 4.75%	6,622 $437,000
Q2 2024 Aug 14, 2024	BUY	$51.18 - $63.75 $134,910 - $168,045	2,636 Added 71.51%	6,322 $383,000
Q4 2023 Feb 14, 2024	SELL	$52.16 - $64.19 $839,984 - $1.03 Million	-16,104 Reduced 81.37%	3,686 $231,000
Q3 2023 Nov 22, 2023	BUY	$57.77 - $65.93 $124,898 - $142,540	2,162 Added 12.26%	19,790 $1.14 Million
Q2 2023 Aug 14, 2023	SELL	$60.95 - $75.51 $162,248 - $201,007	-2,662 Reduced 13.12%	17,628 $1.1 Million
Q1 2023 May 12, 2023	SELL	$70.23 - $86.01 $182,598 - $223,626	-2,600 Reduced 11.36%	20,290 $1.47 Million
Q4 2022 Feb 14, 2023	BUY	$67.18 - $84.11 $208,258 - $260,741	3,100 Added 15.66%	22,890 $1.84 Million
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $123,690 - $154,865	1,869 Added 10.43%	19,790 $1.32 Million
Q2 2022 Aug 12, 2022	SELL	$66.18 - $83.18 $552,272 - $694,137	-8,345 Reduced 31.77%	17,921 $1.36 Million
Q1 2022 May 13, 2022	SELL	$66.02 - $79.71 $334,061 - $403,332	-5,060 Reduced 16.15%	26,266 $2.09 Million
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $15,201 - $17,786	-240 Reduced 0.76%	31,326 $2.3 Million
Q3 2021 Nov 12, 2021	SELL	$68.67 - $84.02 $125,597 - $153,672	-1,829 Reduced 5.48%	31,566 $2.17 Million
Q2 2021 Aug 13, 2021	BUY	$79.87 - $87.53 $1.26 Million - $1.38 Million	15,759 Added 89.36%	33,395 $2.81 Million
Q1 2021 May 14, 2021	BUY	$76.02 - $100.5 $228,820 - $302,505	3,010 Added 20.58%	17,636 $1.43 Million
Q4 2020 Feb 12, 2021	SELL	$80.74 - $97.7 $633,001 - $765,968	-7,840 Reduced 34.9%	14,626 $1.27 Million
Q3 2020 Nov 13, 2020	BUY	$85.07 - $109.69 $428,752 - $552,837	5,040 Added 28.92%	22,466 $2.02 Million
Q2 2020 Aug 14, 2020	SELL	$74.18 - $108.93 $29,672 - $43,572	-400 Reduced 2.24%	17,426 $1.81 Million
Q1 2020 May 14, 2020	SELL	$63.18 - $85.97 $2.23 Million - $3.04 Million	-35,326 Reduced 66.46%	17,826 $1.31 Million
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $1.37 Million - $1.79 Million	18,696 Added 54.26%	53,152 $4.64 Million
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $817,113 - $970,840	11,221 Added 48.29%	34,456 $2.56 Million
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $617,568 - $745,080	8,400 Added 56.62%	23,235 $1.97 Million
Q1 2019 May 14, 2019	BUY	$63.56 - $88.17 $368,648 - $511,386	5,800 Added 64.19%	14,835 $1.28 Million
Q4 2018 Feb 14, 2019	BUY	$58.5 - $69.94 $40,950 - $48,958	700 Added 8.4%	9,035 $575,000
Q3 2018 Nov 14, 2018	SELL	$61.75 - $74.23 $67,925 - $81,653	-1,100 Reduced 11.66%	8,335 $576,000
Q2 2018 Aug 14, 2018	SELL	$60.85 - $83.98 $1.83 Million - $2.52 Million	-30,000 Reduced 76.07%	9,435 $632,000
Q1 2018 May 10, 2018	BUY	$83.06 - $100.98 $1.71 Million - $2.08 Million	20,618 Added 109.57%	39,435 $3.29 Million
Q4 2017 Feb 02, 2018	BUY	$93.56 - $116.6 $17,027 - $21,221	182 Added 0.98%	18,817 $1.78 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $2.03 Million - $2.58 Million	18,635	18,635 $0

Others Institutions Holding INCY

# of Institutions

703

Shares Held

189M

Call Options Held

909K

Put Options Held

447K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.9B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Public Sector Pension Investment Board with notifications on news.

Account

Public Sector Pension Investment Board Incyte Corp Transaction History